Atlas Trials

The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication

Clinical trial NCT04527055 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT04527055
Sponsor
National Cheng-Kung University Hospital
Status
ENROLLING_BY_INVITATION
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori InfectionDysbiosisProbiotics
Start date
2020-05-06
Primary completion
2028-07-31
Enrollment
312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.